Compare CETY & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CETY | LTRN |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6M | 10.0M |
| IPO Year | 2020 | 2020 |
| Metric | CETY | LTRN |
|---|---|---|
| Price | $0.90 | $0.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | 19.5K | ★ 173.4K |
| Earning Date | 12-01-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.65 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $957,633.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.46 | $0.28 |
| 52 Week High | $2.98 | $4.34 |
| Indicator | CETY | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 19.28 |
| Support Level | $0.85 | N/A |
| Resistance Level | $1.04 | $0.84 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 45.45 | 3.01 |
Clean Energy Technologies Inc develop renewable energy products and solutions and establish partnerships in renewable energy that make environmental and economic sense. Its segments are Waste Heat Recovery Solutions - It recycle wasted heat produced in manufacturing, waste to energy and power generation. Waste to Energy Solutions - It convert waste products created in manufacturing, agriculture, wastewater treatment plants and other industries to electricity, renewable natural gas hydrogen and bio char. Engineering, Consulting and Project Management Solutions - It provide power generation, waste to energy, and heat recovery, Procurement and Construction (EPC) services to municipal and industrial customers. It generates majority of revenue from United States followed by International.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.